A group of talented surgeons from the Hôpital Maisonneuve-Rosemont (CIUSSS de l’Est-de-l’Île-de-Montréal) recently accomplished a remarkable feat – they performed the first face transplant in Canada.

Led by the renowned plastic surgeon Dr. Daniel Borsuk, in collaboration with the University of Montréal, this groundbreaking procedure offered new hope to a scarred 64-year-old man.

With this success, the patient became the oldest recipient of a face transplant in history, showcasing the remarkable advancements in medical science and technology.

The procedure, which lasted over thirty hours, required the skills of a diverse team of over one hundred professionals, including physicians, nurses, and other medical staff.

The seamless coordination and collaboration among these experts played a crucial role in the success of the transplant. Additionally, this achievement was made possible by the organ donation facilitated by Transplant Québec, and the compassion and empathy of the donor’s family.

Dr. Borsuk, a professor at the Université de Montréal, expressed his gratitude towards the team and highlighted the combination of science, technology, engineering, and art that went into this delicate operation.

The expertise and experience of the pioneers in face transplantation, combined with innovative approaches, contributed to the success of this transformative procedure.

Four months after the operation, the patient has made incredible progress. He has regained the ability to breathe on his own, chew using his new jaws, smell through his new nose, and speak using his new lips. The patient had suffered from extensive facial scarring due to a gunshot wound seven years ago, which had greatly affected his quality of life.

Despite multiple reconstructive surgeries, he continued to experience physical and emotional pain. The face transplant offered him the opportunity to regain the use of his facial features and ultimately improve his overall well-being.

Yvan Gendron, President and CEO of CIUSSS-EMTL, expressed pride in having excellence in reconstructive surgery within their institution. He emphasized the positive impact this discipline has on transforming lives and restoring a sense of normalcy to patients.

The patient’s life was greatly impacted by the need for a tracheostomy, a surgically created opening in the trachea. Breathing, sleeping, eating, and speaking became immense challenges for him, leading to social isolation and confinement to his home.

Despite being a naturally extroverted individual, his ability to interact with others was severely limited. The face transplant not only offered a solution to these challenges but also provided hope for a fulfilling and active social life.

The surgical team consisted of nine skilled surgeons specializing in plastic surgery, ENT (ear, nose, and throat), and maxillofacial surgery. This unprecedented medical and scientific accomplishment was made possible by the dedication of the entire team.

In addition to the medical expertise, the contributions of various partners were essential to the success of the face transplant. Johnson & Johnson, for example, generously donated medical equipment and surgical items, further supporting the progress of this innovative procedure.

It is important to note that the face transplant process requires extensive preparation for both the medical team and the patient. Years of honing surgical skills and thorough physiological and psychological testing are essential before undertaking such a complex operation. Furthermore, ethical considerations, logistics, and the approval of the donor’s family are crucial steps in the process.

Dr. Borsuk emphasized the importance of ensuring the patient’s physical and mental well-being, both before and after the surgery. The ongoing support provided to the patient will aid in the adaptation to their new life post-transplant.

Face transplants remain a rare procedure worldwide, with approximately forty recorded cases since 2005. The accomplishment of Dr. Borsuk and his team at Hôpital Maisonneuve-Rosemont is not only a significant milestone for Canada but also for Commonwealth countries. Despite the intricacy of the procedure and subsequent rehabilitation, face transplantation proves to be a cost-effective solution when compared to multiple reconstructive surgeries. This procedure allows recipients to lead more productive and fulfilling lives.

Hôpital Maisonneuve-Rosemont is recognized for its excellence in multiple medical specialties, including cranio-maxillofacial surgery. The hospital’s expertise and the skill of Dr. Borsuk, with his background in face reconstruction, have brought about groundbreaking advancements in the field. Their commitment to utilizing virtual surgical methods and 3D models demonstrates a dedication to providing the best possible outcomes for patients.

Dr. Borsuk’s educational background and extensive experience have played a significant role in his pioneering work. His collaboration with renowned face transplant experts, such as Dr. Edouardo Rodriguez, has allowed him to contribute to the annals of facial reconstruction history.

Dr. Borsuk’s innovative techniques, such as using vascularized pelvic bone for facial reconstruction, highlight his dedication to finding effective solutions for patients, including children who require specialized care.

Dr. Borsuk’s achievements are a testament to the continuous advancements in medical science and the profound impact they can have on patients’ lives.

The success of the first face transplant in Canada not only brings hope to individuals in need but also showcases the incredible progress made by the medical community in improving the quality of life for patients.